1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Analysis of the Pharmaceutical Market in Malaysia

Analysis of the Pharmaceutical Market in Malaysia

  • June 2015
  • -
  • Frost & Sullivan
  • -
  • 65 pages

Attractiveness and Hurdles for Stakeholders in the Next 5 Years

The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.

Methodology
- The analysis in this research service is based on the following:

o Information collected through discussions with market participants and from secondary sources, including pharmaceutical companies and medical device companies involved in drug delivery systems, as well as other Web sites and credible sources
o Public announcements and plans by key market leaders, suppliers, new entrants, and others
o Frost & Sullivan’s published research and market and technology expertise
- All market figures and shares listed in the research are Frost & Sullivan's assessment based on its research.
- For Market Engineering research, Frost & Sullivan utilises tried and tested marketing techniques to provide structure to the research and an easy format to compare results across different countries and markets. This project was carried out using primary (telephone) and secondary (published and online material) research as the principle methods of data gathering. The focus of the interviews for this project was primarily the following types of respondents:

o Market participants
o End users
o Key regulatory bodies
o Frost & Sullivan published research services
o Decision support databases
o Country industry forecasts
o Annual reports published by companies

Table Of Contents

Analysis of the Pharmaceutical Market in Malaysia
Executive Summary
Key Findings
Key Questions this Study will Answer

Overview of the Malaysian Healthcare Market
Overview of Malaysian Public and Private Healthcare Systems
Algorithm of Malaysian Healthcare Systems
Algorithm of Private Healthcare Systems
Future Roadblocks

Demand Dynamics in the Malaysian Healthcare Market
Distribution of Household Income Up to 2012
Key Driver in the Malaysian Hospital Market—Growing Admission of Elderly Population
Key Driver in the Malaysian Private Hospital Segment—Medical Tourism
Key Drivers in the Malaysian Hospital Market—Chronic and Lifestyle Diseases

Overview of the Malaysian Pharmaceutical Market
Overview of the Malaysian Pharmaceutical Market
Revenue Forecast for the Malaysian Pharmaceutical Market
Pharmaceutical Market Components by Percentage
Malaysian Pharmaceutical Market—Segmentation
Halal Medicine Market in Malaysia
Malaysian Regulatory Landscape
Key Driver in the Malaysian Pharmaceutical Market—NKEA
Impact of GST on Malaysian Pharmaceutical Market

Drivers and Restraints—Malaysian Pharmaceutical Market
Drivers
Restraints

Profiles of Pharmaceutical Market Participants
Home-grown Participants in the Malaysian Pharmaceutical Market
CCM Pharmaceuticals Sdn Bhd
Kotra Pharma (M) Sdn Bhd
Pharmaniaga Berhad
YSP Industries (M) Sdn Bhd
Hovid Berhad
MNC Participants in the Malaysian Pharmaceutical Market
Pfizer Malaysia
Merck Sharp and Dohme (MSD)
Eli Lilly
GlaxoSmithKline (GSK)
Johnson and Johnson Sdn Bhd

Analysis of the Pharmaceutical Market Participants
PESTLE Analysis
Porter Five Forces Analysis for the Malaysian Pharmaceutical Market

The Future of the Malaysian Pharmaceutical Market
The Future of the Malaysian Pharmaceutical Market—Key Focus Areas
Legal Disclaimer

The Frost and Sullivan Story
Value Proposition: Future of Your Company and Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.